Morristown, NJ (USA), 4 February 2019 – Lonza today announced the expansion of its distribution agreement with Quadra Chemicals Ltd (Quadra) in Canada.
The newly expanded agreement allows Quadra to sell Lonza Consumer Health & Nutrition's full range of consumer health and nutrition ingredients to customers in Canada, including its UC-II® undenatured type II collagen. Lonza's Carnipure® L-Carnitine and ResistAid® natural immune support ingredients are already represented by Quadra in the Canadian market.
Beth Tormey, Sr. Vice President, Head of Global Business Unit, Lonza Consumer Health & Nutrition, commented: “Our expanded agreement with Quadra builds upon an existing five-year relationship with the company. At Lonza we carefully select our strategic partners to ensure that they fit with our strong quality ethos, as well as our customer-driven focus.”
Tormey added, “This latest development enables Quadra to add further science-backed ingredients, such as Lonza's UC-II® undenatured type II collagen, to its existing portfolio, which will provide relevant manufacturers and brand owners in Canada even more choices when creating nutritional supplement formulations, which ultimately benefits consumers.”
Lonza's UC-II® undenatured type II collagen ingredient has been shown in multiple published clinical studies1 2 3 to support optimal joint health by improving joint comfort, mobility and flexibility. Further, because a single, once-a-day dose is just 40 mg, it is also easily incorporated into nutritional supplement combination formulations.